Back to Search
Start Over
G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial
- Source :
- Blood Cancer Journal, Vol 12, Iss 7, Pp 1-4 (2022)
- Publication Year :
- 2022
- Publisher :
- Nature Publishing Group, 2022.
-
Abstract
- Trial registration GA trial is registered under EudraCT#: 2013-001639-38.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20445385
- Volume :
- 12
- Issue :
- 7
- Database :
- Directory of Open Access Journals
- Journal :
- Blood Cancer Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4efbf8e16aa74e82b0aac85f039d3f2c
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41408-022-00698-2